Healthcare
Live Price
Offline$159.89
-1.86% today
1Y Change
+51.53%
Window
Jun 26, 2025 → Jun 18, 2026
Coverage: 246 bars · Jun 26, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
HOYA Corporation (HOCPY) is a Healthcare stock with a market cap of $9.42T and listed on OTC. The stock last traded around $159.89 and up 51.5% across the available one-year price window (Jun 26, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of +12.8%, a dividend yield of 0.9%. What stands out right now is revenue +16.2%, EPS +12.8%, free cash flow +3.0% with operating margin 29.6% and ROIC 18.9%. The dividend is present but secondary, with a yield around 0.9%. Valuation already assumes a fairly strong business story at P/E 38.0 and price/sales 10.3. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines HOCPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HOCPY
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HOCPY Max Drawdown
-16.72%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for HOCPY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$558.3B
-16.7% YoY
FY Net Income
$125.4B
-23.7% YoY
Free Cash Flow
$120.6B
-25.2% YoY
Revenue Growth
+16.2%
EPS Growth
+12.8%
Gross Margin
79.8%
Net Margin
27.3%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 885.8B | 762.6B | 734.1B | 670.3B | 558.3B |
| Gross Profit | 766.3B | 421.7B | 631.9B | 567.3B | 475.0B |
| Operating Income | 480.8B | 353.8B | 346.4B | 317.0B | 263.7B |
| EBITDA | 310.0B | 285.7B | 259.8B | 244.0B | 200.3B |
| Net Income | 202.1B | 181.4B | 168.6B | 164.5B | 125.4B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 534.0B | 525.2B | 405.9B | 419.4B | 334.9B |
| Total Assets | 1234.3B | 1203.6B | 1028.3B | 992.8B | 853.3B |
| Total Liabilities | 262.6B | 241.4B | 213.7B | 203.8B | 180.9B |
| Shareholder Equity | 974.0B | 967.8B | 818.3B | 803.9B | 688.0B |
| Total Debt | 37.3B | 29.2B | 24.6B | 21.6B | 20.7B |
| Net Debt | -496.7B | -495.9B | -381.3B | -397.8B | -314.1B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
151.8B
-20.1% YoY
Capital Expenditures
31.2B
-8.2% YoY
Free Cash Flow
120.6B
-25.2% YoY
Key ratios
Gross Margin
79.8%
Operating Margin
29.6%
Net Margin
27.3%
ROE
25.1%
Debt / Equity
0.04x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.